LISATA THERAPEUTICS, INC. Paid-in-Kind Interest
LISATA THERAPEUTICS, INC. (LSTA) reported Paid-in-Kind Interest of $335.11 thousand for the 3-month period ending 2012-03-31, per its 10-Q filed 2012-05-11.
Discontinued › Cash Flow › Other Cash Flow Items
us-gaap:PaidInKindInterest · last filed 2012-05-11
- LISATA THERAPEUTICS, INC. paid-in-kind interest for the quarter ending 2012-03-31 was $335.11K, a 302.74% increase year-over-year.
- LISATA THERAPEUTICS, INC. paid-in-kind interest for the quarter ending 2011-12-31 was $332.63K.
- LISATA THERAPEUTICS, INC. paid-in-kind interest for the quarter ending 2011-03-31 was $83.21K.
- LISATA THERAPEUTICS, INC. paid-in-kind interest for fiscal 2011 was $661.06K, a 299.27% increase from fiscal 2010.
- LISATA THERAPEUTICS, INC. paid-in-kind interest for fiscal 2010 was $165.57K.
| Period end | Paid-in-Kind Interest 3 month | Paid-in-Kind Interest 6 month | Paid-in-Kind Interest 9 month | Paid-in-Kind Interest 12 month |
|---|---|---|---|---|
| 2012-03-31 | $335.11K 10-Q · filed 2012-05-11 | $667.74K derived: sum of 2 quarters · filed 2012-05-11 | ||
| 2011-12-31 | $332.63K derived: 10-K 12 month − 10-Q 9 month · filed 2012-03-20 | $661.06K 10-K · filed 2012-03-20 | ||
| 2011-09-30 | $328.43K 10-Q · filed 2011-11-10 | |||
| 2011-03-31 | $83.21K 10-Q · filed 2012-05-11 | |||
| 2010-12-31 | $165.57K 10-K · filed 2012-03-20 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B | |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| BIOVIE INC. (BIVI) | United States | $0.012B |